|
Volumn 17, Issue 11, 2003, Pages 2249-2250
|
Amplification of AML1 in acute lymphoblastic leukemia is associated with a poor outcome [9]
a a a a a a a a a b c a |
Author keywords
[No Author keywords available]
|
Indexed keywords
ANTILEUKEMIC AGENT;
ACUTE LYMPHOBLASTIC LEUKEMIA;
BONE MARROW;
CANCER PATIENT;
CANCER RECURRENCE;
CANCER SURVIVAL;
CELL ISOLATION;
CHILD;
CHROMOSOME 21;
CHROMOSOME ANALYSIS;
CHROMOSOME DUPLICATION;
CLINICAL ARTICLE;
CONTROLLED STUDY;
EXON;
FEMALE;
FLUORESCENCE IN SITU HYBRIDIZATION;
FOLLOW UP;
GENE AMPLIFICATION;
HUMAN;
IMMUNOPHENOTYPING;
KARYOTYPE;
LETTER;
LEUKEMIA REMISSION;
LEUKOCYTE COUNT;
MALE;
MONOSOMY;
PRIORITY JOURNAL;
SIDE EFFECT;
SURVIVAL RATE;
TREATMENT OUTCOME;
|
EID: 10744223283
PISSN: 08876924
EISSN: None
Source Type: Journal
DOI: 10.1038/sj.leu.2403140 Document Type: Letter |
Times cited : (95)
|
References (5)
|